Harte Hanks (HHS)
(Delayed Data from NSDQ)
$7.05 USD
+0.07 (1.00%)
Updated Apr 26, 2024 10:59 AM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
Price, Consensus and EPS Surprise
HHS 7.05 +0.07(1.00%)
Will HHS be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for HHS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HHS
Zacks Industry Outlook Highlights Omnicom Group, National CineMedia and Harte Hanks
3 Advertising & Marketing Stocks to Watch Amid Industry Woes
HHS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Interpublic Group (IPG) Lags Q3 Earnings and Revenue Estimates
Stagwell (STGW) Q2 Earnings and Revenues Lag Estimates
Information Services Group (III) Tops Q2 Earnings and Revenue Estimates
Other News for HHS
Harte Hanks to Report First Quarter 2024 Financial Results on May 9, 2024
Harte-Hanks: Q4 Earnings Snapshot
HHS Stock Earnings: Harte-Hanks Beats EPS, Beats Revenue for Q4 2023
Harte Hanks, Inc. (HHS) Q4 2023 Earnings Call Transcript
GOP Sen. John Cornyn Takes Health Secretary To Task Over Cannabis Rescheduling: Xavier Becerra Holds His Own